Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Preferred Shares: 2009-2011

Historic Preferred Shares for Corcept Therapeutics (CORT) over the last 2 years, with Mar 2011 value amounting to $84,000.

  • Corcept Therapeutics' Preferred Shares rose 33.33% to $84,000 in Q1 2011 from the same period last year, while for Mar 2011 it was $84,000, marking a year-over-year increase of 33.33%. This contributed to the annual value of $534,000 for FY2010, which is negligibly% changed negligibly from last year.
  • As of Q1 2011, Corcept Therapeutics' Preferred Shares stood at $84,000, which was down 84.27% from $534,000 recorded in Q4 2010.
  • Corcept Therapeutics' Preferred Shares' 5-year high stood at $534,000 during Q4 2009, with a 5-year trough of $50,000 in Q1 2009.
  • Over the past 3 years, Corcept Therapeutics' median Preferred Shares value was $72,000 (recorded in 2010), while the average stood at $167,667.
  • Data for Corcept Therapeutics' Preferred Shares shows a peak YoY surged of 44.00% (in 2010) over the last 5 years.
  • Corcept Therapeutics' Preferred Shares (Quarterly) stood at $534,000 in 2009, then remained steady at $534,000 in 2010, then skyrocketed by 33.33% to $84,000 in 2011.
  • Its last three reported values are $84,000 in Q1 2011, $534,000 for Q4 2010, and $72,000 during Q3 2010.